Menu

Publications

2014

  1. Adachi, J.*, Kishida, M., Watanabe, S., Hashimoto, Y., Fukamizu, K., and Tomonaga, T.* (2014). Proteome-Wide Discovery of Unknown ATP-Binding Proteins and Kinase Inhibitor Target Proteins Using an ATP Probe. J Proteome Res. 13:5461-70. DOI: 10.1021/pr500845u
  2. Kume H., Muraoka S., Kuga T., Adachi J., Narumi R., Watanabe S., Kuwano M., Kodera Y., Matsushita K., Fukuoka J., Masuda T., Ishihama Y., Matsubara H., Nomura F., and Tomonaga T.* (2014) Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring and tissue microarray analysis. Mol Cell Proteomics 13: 1471-84. DOI: 10.1074/mcp.M113.037093
  3. Kuga, T., Nie H., Kazami T., Satoh M., Matsushita K., Nomura F., Maeshima K., Nakayama Y., and Tomonaga T. (2014) Lamin B2 prevents chromosome instability by ensuring proper mitotic chromosome segregation. Oncogenesis 3:e94. DOI: 10.1038/oncsis.2014.6
  4. Sano S., Tagami S., Hashimoto Y., Yoshizawa-Kumagaye K., Tsunemi M., Okochi M., and Tomonaga T. (2014). Absolute quantitation of low abundance plasma APL1β peptides at sub fmol/mL level by SRM/MRM without immunoaffinity enrichment. J Proteome Res 13: 1012-20. DOI: 10.1021/pr4010103
  5. Yamaguchi S., Zhang B., Tomonaga T., Seino U., Kanagawa A., Segawa M., Nagasaka H., Suzuki A., Miida T., Yamada S., Sasaguri Y., Doi T., Saku K., Okazaki M., Tochino Y., and Hirano K. (2014) Selective evaluation of high density lipoprotein from mouse small intestines by an in situ perfusion technique. J Lipid Res 55: 905-18. DOI: 10.1194/jlr.M047761
  6. Tun, A.W., Chaiyarit, S., Kaewsutthi, S., Katanyoo, W., Chuenkongkaew, W., Kuwano, M., Tomonaga, T., Peerapittayamongkol, C., Thongboonkerd, V., and Lertrit, P. (2014). Profiling the Mitochondrial Proteome of Leber's Hereditary Optic Neuropathy (LHON) in Thailand: Down-Regulation of Bioenergetics and Mitochondrial Protein Quality Control Pathways in Fibroblasts with the 11778G>A Mutation. PLoS One 9, e106779. DOI: 10.1371/journal.pone.0106779
  7. Matsumoto, K., Ikeda, M., Matsumoto, T., Nagashio, R., Nishimori, T., Tomonaga, T., Nomura, F., Sato, Y., Kitasato, H., and Iwamura, M. (2014). Serum periplakin as a potential biomarker for urothelial carcinoma of the urinary bladder. Asian Pac J Cancer Prev 15, 9927-9931. DOI: 10.7314/apjcp.2014.15.22.9927
  8. Matsumoto K., Ikeda M., Sato Y., Kuruma H., Kamata Y., Nishimori T., Tomonaga, T., Nomura, F., Egawa, S., Iwamura, M. (2014) Loss of periplakin expression is associated with pathological stage and cancerspecific survival in patients with urothelial carcinoma of the urinary bladder. Biomed Res 35: 201-6. DOI: 10.2220/biomedres.35.201
  9. Oji Y., Tatsumi N., Fukuda M., Nakatsuka S., Aoyagi S., Hirata E., Nanchi I., Fujiki F., Nakajima H., Yamamoto Y., Shibata S., Nakamura M., Hasegawa K., Takagi S., Fukuda I., Hoshikawa T., Murakami Y, Mori M, Inoue M., Naka T., Tomonaga T., Shimizu Y., Nakagawa M., Hasegawa J., Nezu R., Inohara H., Izumoto S., Nonomura N, Yoshimine T., Okumura M., Morii E., Maeda H., Nishida S., Hosen N, Tsuboi A, Oka Y., and Sugiyama H. (2014) The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers. Int J Oncol 44:1461-9. DOI: 10.3892/ijo.2014.2318
  10. Matsushita K., Shimada H., Ueda Y., Inoue M., Hasegawa M., Tomonaga T., Matsubara H., and Nomura F. (2014) Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy. World J Gastroenterology 20:4316-28. DOI: 10.3748/wjg.v20.i15.4316
  11. Liu, Y., Sogawa, K., Sunaga, M., Umemura, H., Satoh, M., Kazami, T., Yoshikawa, M., Tomonaga, T., Yokosuka, O., and Nomura, F. (2014) Increased concentrations of Apo A-I and Apo A-II fragments in the serum of patients with hepatocellular carcinoma by magnetic beads-assisted MALDI-TOF mass spectrometry. Am J Clin Pathol 141, 52-61. DOI: 10.1309/AJCPBLFBNAP6N2UN